Medicinal cannabis might be increasingly available in many parts of the world, but a new review suggests it has no demonstrable benefit for depression or anxiety disorders.No proven benefit was found ...

Pine Rest's new Pediatric Center of Behavioral Health offers an alternative to emergency rooms for youth experiencing ...

Swedish people with depression and anxiety who took Novo Nordisk A/S’s blockbuster shots Ozempic and Wegovy were less likely ...

Objectives Declining physical fitness, rising obesity and mental and behavioural diagnoses are growing public health issues ...

The goal is to identify depression, anxiety and other mental health risk factors early in students from ages 8-15. The ...

A Swedish national cohort study shows some GLP-1s — semaglutide in particular — are associated with reduced risk of psychiatric decline in patients with depression or anxiety.

When these drugs first became popular, there was a lot of public commentary that claimed taking a GLP-1 was linked with a ...

GLP-1 medications used to treat diabetes and obesity were associated with a reduced need for hospital care and sickness ...

Oceanside, CA - March 18, 2026 - PRESSADVANTAGE - Moment of Clarity has released a new educational resource examining ...

'For anxiety and depression that co-occur with diabetes and obesity, semaglutide and, to a lesser extent, liraglutide might ...

Four years after Russia launched its full-scale invasion, Ukraine faces a growing mental health crisis. Some with severe PTSD ...

Objectives To translate and culturally adapt six self-report measures for depression, anxiety, post-traumatic stress disorder ...